
Does Red Light Therapy Actually Work? 3 Studies, 3 Very Different Answers
The Energy Code
Why PBM Failed for Compound Lifts
Mike explains compound lifts are often limited by coordination and neural drive, not local muscle energetics.
Photobiomodulation (PBM) and low-level light therapy (LLLT) are everywhere, and so are the claims: more ATP, better recovery, fat loss, nervous system balance, strength gains… all from the same “red light” buzzword.
In this 3-paper masterclass, Dr. Mike Belkowski breaks the hype down into evidence, endpoints, and bottlenecks. You’ll get a clean, practical analysis of three very different PBM applications:
-
Body circumference reduction (systematic review of sham-controlled RCTs)
-
Autonomic nervous system regulation using HRV after infra-auricular/vagus-region PBM (randomized controlled trial)
-
Upper-body performance on a real-world compound lift (bench press) in collegiate athletes (double-blind repeated-measures)
Then we connect the dots: why PBM can show a strong signal in one domain, a weak signal in another, and no signal at all when the limiting factor isn’t mitochondrial energy; but coordination, sleep, stress, or recovery terrain.
Bottom line: light is real, but its application is not universal — it works when the tool matches the job.
(Educational content only, not medical advice.)
-
Articles Discussed in Episode:
The influence of photobiomodulation on upper body muscular performance in collegiate athletes
Low-level laser therapy for reducing body circumferences: a systematic review
-
Key Quotes From Dr. Mike:
“The PBM trap is thinking ‘more ATP’ automatically means better everything.”
“Light therapy is real, but real does not mean universal. It means context-dependent.”
“HRV is a moving target — sleep, caffeine, hydration, stress can drown out small effects.”
“If you want nervous system balance, the big levers are still sleep, rhythm, breath, and training load.”
“Ask better questions: what tissue, what depth, what dose, what endpoint?”
-
Key points
-
PBM is a signal, not a guarantee → Match the tool to the job.
-
Paper 1 (LLLT body contouring): short-term circumference reductions beat sham; high satisfaction; good tolerability; only 3 RCTs → promising but early.
-
Devices/wavelengths varied (e.g., 532 nm, 635 nm, 635–680 nm) → can’t yet define “best protocol.”
-
Follow-up windows were short (weeks) → durability still unknown long-term.
-
Mechanism proposed: adipocyte emptying/pores (adipocytolysis / lipid peroxidation) more than guaranteed fat-cell death → lifestyle may determine persistence.
-
Paper 2 (HRV/vagus-region PBM): acute 660 nm infraauricular PBM showed minimal HRV changes in healthy active adults; one entropy metric differed.
-
HRV is a noisy systems output influenced by many variables; acute PBM may be underdosed or target too indirect.
-
Paper 3 (bench press): PBM did not beat sham for 1RM, volume load, or soreness; baseline-to-week improvement likely learning/familiarization, not light.
-
As movement complexity increases, PBM’s effect may drop if the limiter is coordination/neural drive, not local muscle energetics.
-
Core takeaway: PBM efficacy is bottleneck-dependent—hit the bottleneck, see signal; miss it, see nothing.
-
Episode timeline
-
0:02–1:58 Setup: PBM isn’t magic—3 papers, 3 targets, 3 outcomes
-
1:59–14:48 Paper 1: LLLT body circumference systematic review (signal + limits)
-
15:19–21:47 Paper 2: Vagus-region PBM + HRV trial (mostly null; why that matters)
-
22:15–28:57 Paper 3: Bench press performance trial (PBM vs sham; no advantage)
-
29:01–35:19 Compare/contrast: endpoints, bottlenecks, evidence strength, mechanism chain length
-
35:38–37:23 Practical decision framework by goal (contouring vs HRV vs compound strength)
-
37:31–39:55 Final thesis: PBM works sometimes — context, dose, and bottleneck decide
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight:


